In this paper, we aim to focus on false positive results in the evaluation of thyroid aspirations, covering cystic, inflammatory, follicular and oncocytic lesions, papillary carcinoma, and medullary carcinoma of thyroid. The recently described entity noninvasive follicular thyroid neoplasm with papillary-like nuclear features is also discussed detailing the impact of its introduction on the sensitivity and specificity of thyroid FNA, as well as the use of molecular tests for diagnostics. Medicolegal issues in relation to current practice in English law are also described.
| INTRODUCTION
FNAC is widely accepted as a rapid, cost-effective, and safe method for the diagnosis of thyroid nodules although it is accepted that false positive diagnoses of malignancy do occur. 1, 2 The positive predictive value of FNAC for malignancy according to The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is 97%-99%, and this figure includes noninvasive follicular thyroid neoplasm with papillarylike nuclear features (NIFTP) tumours; the sensitivity and specificity of thyroid FNAC have been reported as 65%-99% and 72%-100%, respectively. [1] [2] [3] [4] The Royal College of Pathologists in its 2016 Guidance on the Reporting of Thyroid Cytology Specimens also indicates from review of the published literature a sensitivity for malignancy typically of 65%-98%, a specificity of 76%-100% and a false positive rate of 0%-5%. 5 The results of the fifth UK-wide national audit of 97.9% (1414/1444 cases) and Thy 4 (equivalent to Bethesda Category V) 74.4% (623/837 cases). 6 The main goal of thyroid FNAC is to determine the presence or absence of a neoplasm, then to diagnose any neoplasm present as benign or malignant, and finally to determine the exact type of tumour present. 2, 4, 7 Thyroid FNAC can be used as a rule-in test most of the time for papillary carcinoma but for follicular and medullary carcinomas, for example, thyroid cytology functions as a rule-out test much of the time. In adults, FNA has been established in large reviews as a useful test in the differentiation of a thyroid nodule as malignant or benign. 8, 9 Many research groups have found that FNA in children and adolescents is a highly sensitive and accurate test in differentiating benign from malignant nodules. [10] [11] [12] [13] In a study by Ste-and malignant in TBSRTC is 75.2% and 98.6%, respectively. Overdiagnosis resulting from cytopathology results may lead to excessive treatment, specifically, unnecessary thyroidectomy and also other treatments. Considering the current trend towards conservative treatment for patients with thyroid carcinoma, false positivity can be as problematic as false negativity. In particular, thyroid surgeons could face the experience of performing unnecessary surgery in patients with false positive results. 3 In this paper, we discuss the main causes of false positive in thyroid FNAC (Table 1) . We divided the lesions into two groups: cystic and solid. 
| CYSTIC LESIONS

| Granulomatous thyroiditis
Granulomatous reaction due to subacute thyroiditis (De Quervain's thyroiditis) is much more common than other granulomatous conditions of thyroid such as fungal infections, tuberculosis or sarcoidosis, 4,25 comprising nearly 3%-6% of all thyroid lesions. [25] [26] [27] Localised anterior neck pain, glandular tenderness and diffuse pain in the ears Graves' disease is a common cause of hyperthyroidism and reported rates of malignancy vary between 2.3%-19%. 4 Oncocytic and/or non-oncocytic thyroid follicular epithelial cells, large amounts of flame cells, watery colloid, lymphocytes, and rarely granulomas are seen in aspirations. 24 Cytological findings are challenging, especially after treatment. 32 Distinctive pleomorphism, hyperchromasia, and elongation of nuclei with occasional grooves and inclusions can be seen in this entity. 4, 24, 32 To diagnose PTC in the background of Graves' disease, all the PTC criteria should be present in the aspirates. 24 Figure 6 ).
| FOLLICULAR-PATTER N LE SIONS
In this situation, observing microfollicles out of the clot may be helpful. However, the presence of prominent nucleoli on a background of Hashimoto's thyroiditis is to be interpreted with caution in order to avoid overdiagnosing these nodules as neoplastic. The follicular and oncocytic variants of PTC also remain diagnostic challenges. 44 
| NIFT-P
Recently, a subset of encapsulated FVPTC with a very indolent clinical course was defined when treated with lobectomy alone (without radioactive iodine treatment). This new entity was called NIFTP and there are specific criteria for this diagnosis. 36 Since this lesion is considered a very low risk malignancy but it shares some cytological findings with PTC, it should also be considered a potential cause of false positive results in thyroid FNA. 37 The challenge posed by NIFTP is especially with the suspicious for malignancy and malignant categories, where the FNA diagnosis can frequently prompt initial total thyroidectomy, but where more conservative management (ie, lobectomy) would be preferable if the histological diagnosis proves to be NIFTP. 36 The effects of reclassification of some cases of FVPTC as NIFTP on the risk of malignancy (ROM) associated with the categories of TBSRTC are minimal if strict criteria are used. [37] [38] [39] To avoid false positive FNAC, the six criteria for PTC recommended by TBSRTC are required for a definitive diagnosis of malignancy: enlarged nuclei, oval or irregularly shaped and sometimes moulded nuclei, longitudinal nuclear grooves, intranuclear cytoplasmic pseudoinclusions, pale nuclei with powdery chromatin and marginally placed micronucleoli.
2,39
A recent study involving approximately 500 cases showed that the presence of three or more intranuclear pseudoinclusions is one of the best criteria to discriminate PTC from lesions classified as suspicious at cytology. 39 Samples from FVPTCs demonstrate a microfollicular growth pattern with varying degrees of nuclear alterations (nuclear enlargement, membrane irregularities, and chromatin clearing). If the latter nuclear alterations associated with FVPTC are abundantly present in cytology samples, an accurate presurgical diagnosis of PTC may be rendered. Conversely, when these nuclear alterations are found in few cells, the specificity for malignancy also decreases because these alterations are observed in benign reactive conditions. In the explanatory notes on FVPTC, the TBSRTC states "current practice suggests that only the cases with definitive nuclear features of PTC should be diagnosed unequivocally on FNA". 2 Because the threshold for making a cytopathological diagnosis of malignancy lies in the balance between the sensitivity to diagnose low-grade PTCs such as FVPTC and the specificity to minimise the risk of a false-positive diagnosis, the focus has shifted toward the interpretation of definitive nuclear features.
39,45
Molecular correlation is also indicated since, in many studies, the
NIFTP group of lesions show RAS-like mutations and BRAF V600E
mutations are almost non-existent when the criteria for NIFTP are strictly applied. 39 (See further discussion in the molecular section.)
| PTC
PTC is the most common thyroid malignancy. The pathological diagnosis and classification of PTC is usually based on the microscopic appearance of biopsy specimens. Misdiagnosis of PTC by cytopathological methods has remained one of the most problematic issues in pathology. 3 The pitfalls related to the cytological diagnosis of PTC should be analysed in two parts concerning pattern and nuclear features. It is well known that nuclear details are the core of PTC diagnosis: enlargement, oval shape, membrane irregularity, clearing, longitudinal grooves, intranuclear pseudoinclusions. Among the nuclear features of PTC, the most specific is intranuclear pseudoinclusions. 39 One should be strict to define intranuclear pseudoinclusions, since their presence makes the aspirate at least suspicious for PTC. Intranuclear pseudoinclusions should be large enough and welldelineated with darker outlines to be discriminated from superimposed erythrocytes and artefacts. Nuclear grooves are usually present in PTCs, but to be reliable enough they should be widespread and clear rather than being a focal change or an artificial appearance caused by overlapping cells. Hypochromasia/nuclear clearing is an alerting finding; however. depending on technical issues it might be misleading on its own. Uniformly enlarged oval shaped nuclei are also important in the diagnosis. 1, 3, 4 The patterns of cytological atypia mimicking PTC, formation of papillae or caps, are described in the literature. 1, 4 Pseudopapillary formation as an architectural pitfall is well document by Mahajan et al, 46 who also stated that the presence of intranuclear cytoplasmic pseudoinclusions in parathyroid adenomas not only overlaps with FN, but can also mimic PTC on aspirates.
Psammoma bodies are quite specific for PTC; however dystrophic calcifications and dense colloid bodies should not be interpreted as psammoma bodies as these are almost never laminated in appearance in contrast to psammoma bodies. however, care is also needed not to overdiagnose nuclear and/or pattern atypia in benign entities as PTC. 4 The two categories of the Bethesda System, AUS/FLUS and suspicious for malignancy, are present for these equivocal findings and the degree of atypia determines the appropriate choice in reporting. 
| Medicolegal implications
The expectation of patients and clinicians is that thyroid FNA will work as an effective diagnostic test, but, given its limitations, it is inevitable that false positive cytological diagnoses of malignancy will occur in thyroid FNA cytology. A recent survey of medicolegal claims against the NHS Litigation Authority for thyroid surgery in
England in the period 1995-2012 showed 223 claims related to thyroid surgery, of which 22 cases were related to diagnostic delay or incorrect diagnosis, many of which inevitably involve pathology or cytology. 57 In thyroid FNA cytology, the interobserver and intraobserver differences in diagnosis seen in routine clinical practice between a TBSRTC category VI/Thy 5 diagnosis and TBSRTC category V/Thy 4 are frequently quite subjective and are often a matter of professional opinion among trained and experienced cytopathologists rather than a matter of fact. 
| CONCLUSIONS
The main role of thyroid FNAC is the triage of patients who actually require surgery, thus reducing the number of unnecessary thyroidectomies and possible complications. 60 Ultrasound image features must be taken into account to plan appropriate patient management in a multidisciplinary approach to patient management. A cytology result with suspicious or malignant findings in the presence of a nodule with benign ultrasound features should be carefully studied to avoid a false positive diagnosis. As a cytological diagnosis of malignancy may require aggressive surgical treatment, including total thyroidectomy with possible central neck dissection, the correct FNA diagnosis is important to guide proper management of patients and to avoid overtreatment. In some cases if there is still uncertainty cell block immunohistochemistry of the current specimen or of a repeat thyroid FNAC and/or core biopsy will allow confirmation of the presence of malignancy and also the exact nature of the malignancy (eg, medullary carcinoma or poorly differentiated carcinoma). Molecular testing including for BRAF V600E mutation may also be helpful.
All centres should audit their own practice of both thyroid cytology and histology to identify the risk of malignancy for all subcategories of thyroid FNAC, whether using TBSRTC, UK RCPath Thy or another internationally recognised terminology system bearing also in mind that the histopathological diagnosis may also be subject to significant interobserver variation. 60 It is important to note that an accurate diagnosis by FNA crucially depends on the sample being representative and adequate in cellularity, appropriately processed, and stained, in order to provide high-quality preparations for assessment. When these conditions are not met, repeat sampling with or without onsite assessment should be considered prior to surgical management.
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